Allegion PLC has a consensus price target of $127.36 based on the ratings of 12 analysts. The high is $150 issued by Mizuho on October 17, 2024. The low is $100 issued by Vertical Research on October 19, 2023. The 3 most-recent analyst ratings were released by Barclays, Morgan Stanley, and Wells Fargo on March 26, 2025, February 19, 2025, and February 19, 2025, respectively. With an average price target of $133.33 between Barclays, Morgan Stanley, and Wells Fargo, there's an implied 2.41% upside for Allegion PLC from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
03/26/2025 | Buy Now | -3.22% | Barclays | Julian Mitchell73% | $130 → $126 | Maintains | Underweight | Get Alert |
02/19/2025 | Buy Now | 6.77% | Morgan Stanley | Joshua Pokrzywinski74% | $137 → $139 | Maintains | Equal-Weight | Get Alert |
02/19/2025 | Buy Now | 3.69% | Wells Fargo | Joseph O'Dea58% | $140 → $135 | Maintains | Equal-Weight | Get Alert |
02/19/2025 | Buy Now | 10.61% | Baird | Timothy Wojs63% | $152 → $144 | Maintains | Neutral | Get Alert |
02/19/2025 | Buy Now | -0.15% | Barclays | Julian Mitchell73% | $134 → $130 | Maintains | Underweight | Get Alert |
01/08/2025 | Buy Now | 2.93% | Barclays | Julian Mitchell73% | $137 → $134 | Maintains | Underweight | Get Alert |
01/07/2025 | Buy Now | 7.54% | Wells Fargo | Joseph O'Dea58% | $152 → $140 | Maintains | Equal-Weight | Get Alert |
10/28/2024 | Buy Now | 5.23% | Barclays | Julian Mitchell73% | $135 → $137 | Maintains | Underweight | Get Alert |
10/25/2024 | Buy Now | 16.75% | Baird | Timothy Wojs63% | $145 → $152 | Maintains | Neutral | Get Alert |
10/17/2024 | Buy Now | 15.22% | Mizuho | Brett Linzey69% | $135 → $150 | Maintains | Neutral | Get Alert |
10/07/2024 | Buy Now | 16.75% | Wells Fargo | Joseph O'Dea58% | $137 → $152 | Maintains | Equal-Weight | Get Alert |
10/02/2024 | Buy Now | 3.69% | Barclays | Julian Mitchell73% | $117 → $135 | Maintains | Underweight | Get Alert |
07/25/2024 | Buy Now | 5.23% | Wells Fargo | Joseph O'Dea58% | $125 → $137 | Maintains | Equal-Weight | Get Alert |
07/25/2024 | Buy Now | -10.13% | Barclays | Julian Mitchell73% | $112 → $117 | Maintains | Underweight | Get Alert |
07/10/2024 | Buy Now | -13.97% | Barclays | Julian Mitchell73% | $116 → $112 | Maintains | Underweight | Get Alert |
07/10/2024 | Buy Now | -3.99% | Wells Fargo | Joseph O'Dea58% | $141 → $125 | Maintains | Equal-Weight | Get Alert |
06/04/2024 | Buy Now | -10.9% | Barclays | Julian Mitchell73% | $122 → $116 | Downgrade | Equal-Weight → Underweight | Get Alert |
04/16/2024 | Buy Now | 1.39% | UBS | Chris Snyder70% | $113 → $132 | Maintains | Neutral | Get Alert |
04/02/2024 | Buy Now | -6.29% | Barclays | Julian Mitchell73% | $121 → $122 | Maintains | Equal-Weight | Get Alert |
02/23/2024 | Buy Now | 8.3% | Mizuho | Brett Linzey69% | $140 → $141 | Downgrade | Buy → Neutral | Get Alert |
02/21/2024 | Buy Now | -7.06% | Barclays | Julian Mitchell73% | $119 → $121 | Maintains | Equal-Weight | Get Alert |
02/21/2024 | Buy Now | 7.54% | Wells Fargo | Joseph O'Dea58% | $139 → $140 | Downgrade | Overweight → Equal-Weight | Get Alert |
12/19/2023 | Buy Now | 6.77% | Wells Fargo | Joseph O'Dea58% | $119 → $139 | Maintains | Overweight | Get Alert |
12/04/2023 | Buy Now | -8.6% | Barclays | Julian Mitchell73% | $130 → $119 | Downgrade | Overweight → Equal-Weight | Get Alert |
10/19/2023 | Buy Now | -23.19% | Vertical Research | Jeffrey Sprague79% | $128 → $100 | Downgrade | Buy → Hold | Get Alert |
09/06/2023 | Buy Now | — | Longbow Research | David Macgregor59% | — | Downgrade | Buy → Neutral | Get Alert |
07/27/2023 | Buy Now | -2.45% | Morgan Stanley | Joshua Pokrzywinski74% | $120 → $127 | Maintains | Equal-Weight | Get Alert |
07/12/2023 | Buy Now | -7.83% | Morgan Stanley | Joshua Pokrzywinski74% | $120 → $120 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
07/10/2023 | Buy Now | -0.15% | Barclays | Julian Mitchell73% | $120 → $130 | Maintains | Overweight | Get Alert |
05/01/2023 | Buy Now | -0.15% | Wells Fargo | Joe O'Dea64% | $116 → $130 | Maintains | Overweight | Get Alert |
04/27/2023 | Buy Now | -8.6% | Morgan Stanley | Joshua Pokrzywinski74% | $120 → $119 | Maintains | Equal-Weight | Get Alert |
04/27/2023 | Buy Now | -3.22% | Baird | Timothy Wojs63% | $130 → $126 | Maintains | Neutral | Get Alert |
04/14/2023 | Buy Now | -8.6% | Goldman Sachs | Joe Ritchie74% | $138 → $119 | Maintains | Buy | Get Alert |
04/13/2023 | Buy Now | -10.9% | Wells Fargo | Joseph O'Dea58% | $130 → $116 | Maintains | Overweight | Get Alert |
04/06/2023 | Buy Now | -7.83% | Barclays | Julian Mitchell73% | $129 → $120 | Maintains | Overweight | Get Alert |
02/23/2023 | Buy Now | -1.68% | Mizuho | Brett Linzey69% | $123 → $128 | Maintains | Buy | Get Alert |
02/23/2023 | Buy Now | -8.6% | Morgan Stanley | Joshua Pokrzywinski74% | $108 → $119 | Maintains | Equal-Weight | Get Alert |
02/06/2023 | Buy Now | 1.39% | Baird | Timothy Wojs63% | $116 → $132 | Maintains | Neutral | Get Alert |
01/19/2023 | Buy Now | -0.15% | Wells Fargo | Joe O'Dea64% | $121 → $130 | Maintains | Overweight | Get Alert |
01/13/2023 | Buy Now | -5.52% | Mizuho | Brett Linzey69% | $114 → $123 | Maintains | Buy | Get Alert |
01/06/2023 | Buy Now | -17.04% | Morgan Stanley | Joshua Pokrzywinski74% | $107 → $108 | Maintains | Equal-Weight | Get Alert |
01/05/2023 | Buy Now | -7.06% | Wells Fargo | Joe O'Dea64% | $116 → $121 | Maintains | Overweight | Get Alert |
01/05/2023 | Buy Now | -0.91% | Barclays | Julian Mitchell73% | $127 → $129 | Maintains | Overweight | Get Alert |
01/03/2023 | Buy Now | -1.68% | Vertical Research | Jeffrey Sprague79% | → $128 | Upgrade | Hold → Buy | Get Alert |
12/01/2022 | Buy Now | -2.45% | Barclays | Julian Mitchell73% | $118 → $127 | Maintains | Overweight | Get Alert |
10/28/2022 | Buy Now | -17.81% | Morgan Stanley | Joshua Pokrzywinski74% | $98 → $107 | Maintains | Equal-Weight | Get Alert |
10/28/2022 | Buy Now | -10.9% | Wells Fargo | Joseph O'Dea58% | $114 → $116 | Maintains | Overweight | Get Alert |
10/28/2022 | Buy Now | -10.9% | Credit Suisse | John Walsh77% | $108 → $116 | Maintains | Neutral | Get Alert |
10/12/2022 | Buy Now | -24.73% | Morgan Stanley | Joshua Pokrzywinski74% | $117 → $98 | Maintains | Equal-Weight | Get Alert |
10/03/2022 | Buy Now | -11.67% | Barclays | Julian Mitchell73% | $125 → $115 | Maintains | Overweight | Get Alert |
09/21/2022 | Buy Now | -12.44% | Mizuho | Brett Linzey69% | $125 → $114 | Maintains | Buy | Get Alert |
08/01/2022 | Buy Now | -12.44% | Wells Fargo | Joseph O'Dea58% | $115 → $114 | Maintains | Overweight | Get Alert |
07/29/2022 | Buy Now | -10.13% | Morgan Stanley | Joshua Pokrzywinski74% | $115 → $117 | Maintains | Equal-Weight | Get Alert |
07/18/2022 | Buy Now | -10.9% | Baird | Timothy Wojs63% | $120 → $116 | Maintains | Neutral | Get Alert |
07/18/2022 | Buy Now | -3.99% | Mizuho | Brett Linzey69% | $145 → $125 | Maintains | Buy | Get Alert |
07/13/2022 | Buy Now | -11.67% | Wells Fargo | Joseph O'Dea58% | $118 → $115 | Maintains | Overweight | Get Alert |
07/11/2022 | Buy Now | -15.51% | B of A Securities | Andrew Obin71% | $130 → $110 | Downgrade | Neutral → Underperform | Get Alert |
07/08/2022 | Buy Now | -3.99% | Barclays | Julian Mitchell73% | $140 → $125 | Maintains | Overweight | Get Alert |
07/06/2022 | Buy Now | -7.83% | Baird | Timothy Wojs63% | $135 → $120 | Maintains | Neutral | Get Alert |
06/29/2022 | Buy Now | -9.36% | Wells Fargo | Joe O'Dea64% | $130 → $118 | Maintains | Overweight | Get Alert |
06/23/2022 | Buy Now | -13.2% | Goldman Sachs | Joe Ritchie74% | $140 → $113 | Maintains | Buy | Get Alert |
05/31/2022 | Buy Now | -11.67% | Morgan Stanley | Joshua Pokrzywinski74% | $120 → $115 | Maintains | Equal-Weight | Get Alert |
04/27/2022 | Buy Now | -2.45% | Credit Suisse | John Walsh77% | $132 → $127 | Maintains | Neutral | Get Alert |
04/27/2022 | Buy Now | -7.83% | Morgan Stanley | Joshua Pokrzywinski74% | $130 → $120 | Maintains | Equal-Weight | Get Alert |
04/27/2022 | Buy Now | -0.15% | Wells Fargo | Joseph O'Dea58% | $132 → $130 | Maintains | Overweight | Get Alert |
04/20/2022 | Buy Now | 3.69% | Baird | Timothy Wojs63% | $140 → $135 | Maintains | Neutral | Get Alert |
04/07/2022 | Buy Now | 1.39% | Wells Fargo | Joseph O'Dea58% | $147 → $132 | Maintains | Overweight | Get Alert |
04/07/2022 | Buy Now | -0.15% | Morgan Stanley | Joshua Pokrzywinski74% | $134 → $130 | Maintains | Equal-Weight | Get Alert |
04/07/2022 | Buy Now | 5.23% | Goldman Sachs | Joe Ritchie74% | $153 → $137 | Maintains | Buy | Get Alert |
04/04/2022 | Buy Now | 15.22% | Barclays | Julian Mitchell73% | $160 → $150 | Maintains | Overweight | Get Alert |
The latest price target for Allegion (NYSE:ALLE) was reported by Barclays on March 26, 2025. The analyst firm set a price target for $126.00 expecting ALLE to fall to within 12 months (a possible -3.22% downside). 19 analyst firms have reported ratings in the last year.
The latest analyst rating for Allegion (NYSE:ALLE) was provided by Barclays, and Allegion maintained their underweight rating.
The last upgrade for Allegion PLC happened on January 3, 2023 when Vertical Research raised their price target to $128. Vertical Research previously had a hold for Allegion PLC.
The last downgrade for Allegion PLC happened on June 4, 2024 when Barclays changed their price target from $122 to $116 for Allegion PLC.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Allegion, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Allegion was filed on March 26, 2025 so you should expect the next rating to be made available sometime around March 26, 2026.
While ratings are subjective and will change, the latest Allegion (ALLE) rating was a maintained with a price target of $130.00 to $126.00. The current price Allegion (ALLE) is trading at is $130.19, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.